Zara E. Ranglin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zara E. Ranglin has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Akiko Iwasaki
Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
1 shared publication - Anna Marie Pyle
Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA
1 shared publication - Anne Maria Hahn
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA
1 shared publication - Benjamin Israelow
Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
1 shared publication Brett D. Lindenbach
Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, USA
1 shared publication- Bridget L. Menasche
Departments of Laboratory Medicine and Immunobiology, Yale University, New Haven, USA
1 shared publication
Latest Publications
- 29 July 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (8) , 2038-2050
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity
Circulating bat coronaviruses represent a pandemic threat. However, our understanding of bat coronavirus pathogenesis and transmission potential is limited by the lack of phenotypically characterized strains. We created molecular clones for the two closest known relatives of SARS-CoV-2, BANAL-52 and BANAL-236. We demonstrated that BANAL-CoVs and SARS-CoV-2 have similar replication kinetics in human bronchial epithelial cells. However, BANAL-CoVs have impaired replication in human nasal epithelial cells and in the upper airway of mice. We also observed reduced pathogenesis in mice and diminished transmission in hamsters. Further, we observed that diverse bat coronaviruses evade interferon and downregulate major histocompatibility complex class I. Collectively, our study demonstrates that despite high genetic similarity across bat coronaviruses, prediction of pandemic potential of a virus necessitates functional characterization. Finally, the restriction of bat coronavirus replication in the upper airway highlights that transmission potential and innate immune restriction can be uncoupled in this high-risk family of emerging viruses.
- 29 July 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (8) , 2038-2050
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity
Circulating bat coronaviruses represent a pandemic threat. However, our understanding of bat coronavirus pathogenesis and transmission potential is limited by the lack of phenotypically characterized strains. We created molecular clones for the two closest known relatives of SARS-CoV-2, BANAL-52 and BANAL-236. We demonstrated that BANAL-CoVs and SARS-CoV-2 have similar replication kinetics in human bronchial epithelial cells. However, BANAL-CoVs have impaired replication in human nasal epithelial cells and in the upper airway of mice. We also observed reduced pathogenesis in mice and diminished transmission in hamsters. Further, we observed that diverse bat coronaviruses evade interferon and downregulate major histocompatibility complex class I. Collectively, our study demonstrates that despite high genetic similarity across bat coronaviruses, prediction of pandemic potential of a virus necessitates functional characterization. Finally, the restriction of bat coronavirus replication in the upper airway highlights that transmission potential and innate immune restriction can be uncoupled in this high-risk family of emerging viruses.